Hint mode is switched on Switch off

SBIO - ALPS Medical Breakthroughs ETF (USD) (US00162Q5936)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US00162Q5936
SBIO ISIN
Exchange Traded Funds (ETF)
Type of fund
ALPS Advisors
Provider
63.5 USD
NAV per Share | 03/08/2026
29/12/2014
Inception Date
1 times per year
Dividend payments
CEOJMS
CFI
SBIO
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S-Network Medical Breakthroughs Index
Benchmark
0.5 %
Total Cost Ratio
201.62 mln USD
Fund NAV | 03/08/2026
201.62 mln USD
Share Class NAV | 03/08/2026
No
UCITS
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Yield on 03/08/2026, NYSE Arca

  • YTD
    2.79 %
  • 1M
    -10.49 %
  • 3M
    1.88 %
  • 6M
    10.17 %
  • 1Y
    81.6 %
  • 3Y
    68.94 %
  • 5Y
    16.03 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (SBIO)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

SBIO profile

The ALPS Medical Breakthroughs ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The ALPS Advisors fund’s base currency is USD and the share class was registered 29.12.2014 with unique ISIN - US00162Q5936. Main exchange is NYSE Arca and ticker symbol is SBIO. The total expense ratio is 0.5%. The ALPS Medical Breakthroughs ETF (USD) pays dividends 1 time(s) per year.

Structure SBIO on 03/08/2026

Download structure in Excel
Paper Value
Crinetics Pharmaceuticals Inc. 4.76%
Apogee Therapeutics Inc. 4.48%
CG oncology Inc. 3.29%
Xenon Pharmaceuticals Inc. 3.24%
Dianthus Therapeutics Inc. 3.12%
Oruka Therapeutics Inc. 3.08%
Travere Therapeutics Inc. 2.76%
Definium Therapeutics Inc. 2.46%
ACADIA Pharmaceuticals Inc. 2.36%
VeraDermics Inc. 2.29%
Dyne Therapeutics Inc. 2.25%
Edgewise Therapeutics Inc. 2.23%
Relay Therapeutics Inc. 2.2%
Denali Therapeutics Inc. 1.98%
Structure Therapeutics Inc. 1.85%
Newamsterdam Pharma Co. NV 1.73%
Ideaya Biosciences Inc. 1.68%
MBX Biosciences Inc. 1.65%
Celldex Therapeutics Inc. 1.59%
Disc Medicine Inc. 1.57%
Tarsus Pharmaceuticals Inc. 1.42%
Immunome Inc. 1.41%
Nektar Therapeutics 1.29%
Vericel Corp. 1.27%
Vera Therapeutics Inc. 1.25%
Mineralys Therapeutics Inc. 1.22%
Kailera Therapeutics Inc. 1.21%
BioCryst Pharmaceuticals Inc. 1.21%
Amylyx Pharmaceuticals Inc. 1.21%
Sionna Therapeutics Inc. 1.2%
Nuvation Bio Inc. 1.16%
Viridian Therapeutics Inc. 1.15%
SELLAS Life Sciences Group Inc. 1.13%
Palvella Therapeutics Inc. 1.08%
Zai Lab Ltd. 1.07%
Zenas Biopharma Inc. 1.06%
Rapport Therapeutics Inc. 1.05%
Tyra Biosciences Inc. 1.03%
Generate Biomedicines Inc. 0.99%
Stoke Therapeutics Inc. 0.99%
Agios Pharmaceuticals Inc. 0.98%
Lakefront Biotherapeutics NV 0.94%
Bicara Therapeutics Inc. 0.91%
Sarepta Therapeutics Inc. 0.9%
Taysha Gene Therapies Inc. 0.9%
Immunocore Holdings PLC 0.89%
Compass Pathways PLC 0.82%
Maze Therapeutics Inc. 0.82%
Xencor Inc. 0.77%
ArriVent Biopharma Inc. 0.74%
LB Pharmaceuticals Inc. 0.67%
Immatics NV 0.65%
MannKind Corp. 0.63%
Vor BioPharma Inc. 0.63%
Corvus Pharmaceuticals Inc. 0.61%
Seaport Therapeutics Inc. 0.6%
WaVe Life Sciences Ltd. 0.59%
MeiraGTx Holdings PLC 0.59%
Olema Pharmaceuticals Inc. 0.53%
Alto Neuroscience Inc. 0.52%
Theravance Biopharma Inc. 0.47%
Geron Corp. 0.44%
Kura Oncology Inc. 0.44%
Solid Biosciences Inc. 0.43%
Design Therapeutics Inc. 0.43%
Aclaris Therapeutics Inc. 0.42%
SpyGlass Pharma Inc. 0.41%
Candel Therapeutics Inc. 0.4%
Rigel Pharmaceuticals Inc. 0.37%
Oculis Holding AG 0.37%
Climb Bio Inc. 0.37%
AgomAb Therapeutics NV 0.36%
Allogene Therapeutics Inc. 0.34%
Altimmune Inc. 0.32%
Relmada Therapeutics Inc. 0.3%
4D Molecular Therapeutics Inc. 0.29%
Tectonic Therapeutic Inc. 0.29%
Zura Bio Ltd. 0.28%
Contineum Therapeutics Inc. 0.28%
Neurogene Inc. 0.28%
Fulgent Genetics Inc. 0.27%
Eikon Therapeutics Inc. 0.27%
Rezolute Inc. 0.26%
Delcath Systems Inc. 0.24%
Evommune Inc. 0.23%
C4 Therapeutics Inc. 0.21%
X4 Pharmaceuticals Inc. 0.21%
Tenax Therapeutics Inc. 0.21%
Enanta Pharmaceuticals Inc. 0.2%
Akebia Therapeutics Inc. 0.19%
Upstream Bio Inc. 0.19%
Compass Therapeutics Inc. 0.18%
Inhibikase Therapeutics Inc. 0.16%
SAB Biotherapeutics Inc. 0.16%
Anavex Life Sciences Corp. 0.15%
Immuneering Corp. 0.15%
Fulcrum Therapeutics Inc. 0.13%
MacroGenics Inc. 0.13%
Protara Therapeutics Inc. 0.12%
Bicycle Therapeutics PLC 0.11%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.